Citadel Advisors LLC 13D and 13G filings for Harpoon Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 6:18 pm Sale |
2023-12-31 | 13G | Harpoon Therapeutics, Inc. HARP |
Citadel Advisors LLC | 1,027,956 6.000% |
-3 (-0.00%) |
Filing |
| 2023-11-06 4:34 pm Purchase |
2023-10-25 | 13G | Harpoon Therapeutics, Inc. HARP |
Citadel Advisors LLC | 1,027,959 6.000% |
1,027,959 (New Position) |
Filing |